GSTP1 and chromophobe renal cell carcinoma: Interestingly, carriers of GSTP1 IleVal+ValVal (variant) genotype (77% of cRCC patients compared to 58% of controls) were at 3.14-fold increased risk of cRCC (95%CI:1.54–6.43, p<0.001) (Table 3).